在BioDeep NovoCell知识数据库中,参考离子总共被划分为4个级别。
  • Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
  • Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
  • Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
  • Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。

Found 23 Reference Ions Near m/z 843.5184
NovoCell ID m/z Mass Window Metabolite Ranking Anatomy Context
MSI_000043825 Reliable 843.5203 843.52 ~ 843.5208
MzDiff: 3.4 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
8.03 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000058304 Reliable 843.5203 843.52 ~ 843.5208
MzDiff: 3.4 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
8.03 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000058424 Reliable 843.5203 843.52 ~ 843.5208
MzDiff: 3.4 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
8.03 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000062044 Reliable 843.5203 843.52 ~ 843.5208
MzDiff: 3.4 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
8.03 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000063012 Reliable 843.5203 843.52 ~ 843.5208
MzDiff: 3.4 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
8.03 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000063401 Reliable 843.5203 843.52 ~ 843.5208
MzDiff: 3.4 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
8.03 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000063655 Reliable 843.5203 843.52 ~ 843.5208
MzDiff: 3.4 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
8.03 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000063706 Reliable 843.5203 843.52 ~ 843.5208
MzDiff: 3.4 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
8.03 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000064795 Reliable 843.5203 843.52 ~ 843.5208
MzDiff: 3.4 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
8.03 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000055566 Reliable 843.5203 843.52 ~ 843.5208
MzDiff: 3.4 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
5.1 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000065090 Unreliable 843.5196 843.5192 ~ 843.5198
MzDiff: 2.3 ppm
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
4.55 (100%) Homo sapiens
[UBERON:0001043] esophagus
MSI_000052380 Unreliable 843.5106 843.5106 ~ 843.5106
MzDiff: none
PG(18:1(11Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) (BioDeep_00000193933)
Formula: C44H75O13P (842.4945)
2.12 (100%) Homo sapiens
[UBERON:0001052] rectum
MSI_000047381 Unreliable 843.5112 843.5112 ~ 843.5112
MzDiff: none
PG(18:1(11Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) (BioDeep_00000193933)
Formula: C44H75O13P (842.4945)
2.33 (100%) Homo sapiens
[UBERON:0013067] colorectal mucosa
MSI_000051854 Unreliable 843.5191 843.5191 ~ 843.5191
MzDiff: none
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
2.41 (100%) Homo sapiens
[UBERON:0001052] rectum
MSI_000047340 Unreliable 843.5196 843.5196 ~ 843.5196
MzDiff: none
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
2.37 (100%) Homo sapiens
[UBERON:0013067] colorectal mucosa
MSI_000052504 Unreliable 843.527 843.527 ~ 843.527
MzDiff: none
PA(22:2(13Z,16Z)/6 keto-PGF1alpha) (BioDeep_00000190782)
Formula: C45H79O12P (842.5309)
1.9 (100%) Homo sapiens
[UBERON:0001052] rectum
MSI_000047334 Unreliable 843.5276 843.5276 ~ 843.5276
MzDiff: none
PA(22:2(13Z,16Z)/6 keto-PGF1alpha) (BioDeep_00000190782)
Formula: C45H79O12P (842.5309)
2.38 (100%) Homo sapiens
[UBERON:0013067] colorectal mucosa
MSI_000065328 Unreliable 843.5191 843.5191 ~ 843.5191
MzDiff: none
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
2.43 (100%) Homo sapiens
[UBERON:0001155] colon
MSI_000011991 Unavailable 843.5221 843.5221 ~ 843.5221
MzDiff: 0.1 ppm
Spiramycin (BioDeep_00000397813)
Formula: C43H74N2O14 (842.514)
-0.73 (100%) Bathymodiolus
[UBERON:2000211] gill lamella
MSI_000044411 Unavailable 843.5132 843.5132 ~ 843.5132
MzDiff: none
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
-0.17 (100%) Rattus norvegicus
[UBERON:0002264] olfactory bulb
MSI_000056148 Unavailable 843.5213 843.5213 ~ 843.5213
MzDiff: none
Vinaginsenoside R1 (BioDeep_00000020449)
Formula: C44H74O15 (842.5027)
-0.56 (100%) Homo sapiens
[UBERON:0007779] transudate
MSI_000009931 Unreliable 843.5219 843.5219 ~ 843.5219
MzDiff: none
Spiramycin (BioDeep_00000397813)
Formula: C43H74N2O14 (842.514)
1.92 (100%) Bathymodiolus
[UBERON:0009120] gill filament
MSI_000050002 Unreliable 843.5252 843.5252 ~ 843.5252
MzDiff: none
Spiramycin (BioDeep_00000397813)
Formula: C43H74N2O14 (842.514)
1.23 (100%) Mytilus edulis
[UBERON:0009120] gill filament

Found 31 Sample Hits
Metabolite Species Sample
Spiramycin

Formula: C43H74N2O14 (842.514)
Adducts: [M+H]+ (Ppm: 1)
Bathymodiolus (epithelial host cells)
MPIMM_054_QE_P_BP_CF_Bputeoserpentis_MALDI-FISH8_Sl16_s1_DHB_233x233_3um
Resolution: 3μm, 233x233

Description

Spiramycin

Formula: C43H74N2O14 (842.514)
Adducts: [M+H]+ (Ppm: 0.8)
Bathymodiolus (epithelial host cells)
MPIMM_039_QE_P_BP_CF_Bputeoserpentis_MALDI-FISH8_Sl14_s1_DHB_233x233_3um
Resolution: 3μm, 233x234

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 12.2)
Homo sapiens (esophagus)
LNTO22_1_3
Resolution: 75μm, 121x68

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 7.8)
Homo sapiens (esophagus)
LNTO22_1_4
Resolution: 17μm, 82x80

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 9.3)
Homo sapiens (esophagus)
TO42T
Resolution: 17μm, 69x81

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 12.8)
Homo sapiens (esophagus)
LNTO22_1_9
Resolution: 75μm, 89x74

Description

PA(22:2(13Z,16Z)/6 keto-PGF1alpha)

Formula: C45H79O12P (842.5309)
Adducts: [M+H]+ (Ppm: 11.8)
Mus musculus (Liver)
Salmonella_final_pos_recal
Resolution: 17μm, 691x430

Description

A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium. [dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671.

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 10.3)
Homo sapiens (esophagus)
LNTO30_8M_1
Resolution: 17μm, 69x54

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 11.4)
Homo sapiens (colorectal adenocarcinoma)
80TopL, 50TopR, 70BottomL, 60BottomR-profile
Resolution: 17μm, 137x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 7.8)
Homo sapiens (colorectal adenocarcinoma)
520TopL, 490TopR, 510BottomL, 500BottomR-profile
Resolution: 17μm, 147x131

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 10.8)
Homo sapiens (colorectal adenocarcinoma)
439TopL, 409TopR, 429BottomL, 419BottomR-profile
Resolution: 17μm, 157x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 5.7)
Homo sapiens (NA)
160TopL,130TopR,150BottomL,140BottomR-profile
Resolution: 17μm, 142x136

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 9.9)
Homo sapiens (esophagus)
LNTO29_16_3
Resolution: 17μm, 108x107

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 12.1)
Homo sapiens (esophagus)
LNTO26_7_1
Resolution: 17μm, 75x74

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 13.4)
Homo sapiens (esophagus)
LNTO26_7_2
Resolution: 17μm, 135x101

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 11.8)
Homo sapiens (esophagus)
LNTO26_7_3
Resolution: 75μm, 82x88

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 10.6)
Homo sapiens (esophagus)
TO41T
Resolution: 75μm, 69x43

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 10.4)
Homo sapiens (esophagus)
LNTO30_17_2
Resolution: 75μm, 82x54

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 12.3)
Homo sapiens (esophagus)
LNTO22_1_5
Resolution: 75μm, 135x94

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 12.1)
Homo sapiens (esophagus)
LNTO22_1_7
Resolution: 75μm, 69x54

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 11.6)
Homo sapiens (esophagus)
LNTO22_1_8
Resolution: 75μm, 69x61

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 11.4)
Homo sapiens (esophagus)
LNTO22_2_1
Resolution: 75μm, 89x88

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 12.4)
Homo sapiens (esophagus)
LNTO22_2_2
Resolution: 75μm, 135x94

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 11.9)
Homo sapiens (esophagus)
LNTO26_16_1
Resolution: 75μm, 95x88

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 10.1)
Homo sapiens (esophagus)
LNTO29_18_2
Resolution: 75μm, 62x68

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 10.9)
Homo sapiens (esophagus)
LNTO30_7_1
Resolution: 75μm, 69x68

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 10.5)
Homo sapiens (esophagus)
LNTO30_7_2
Resolution: 75μm, 82x68

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 10.1)
Homo sapiens (colorectal adenocarcinoma)
240TopL, 210TopR, 230BottomL, 220BottomR-centroid
Resolution: 50μm, 142x141

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 10.8)
Homo sapiens (colorectal adenocarcinoma)
200TopL, 170TopR, 190BottomL, 180BottomR-centroid
Resolution: 50μm, 132x126

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 9.9)
Homo sapiens (colorectal adenocarcinoma)
160TopL,130TopR,150BottomL,140BottomR-centroid
Resolution: 50μm, 142x136

Description

Vinaginsenoside R1

Formula: C44H74O15 (842.5027)
Adducts: [M+H]+ (Ppm: 10.6)
Homo sapiens (colorectal adenocarcinoma)
120TopL, 90TopR, 110BottomL, 100BottomR-centroid
Resolution: 50μm, 132x136

Description